{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:10:26Z","timestamp":1790885426574,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014984","name":"Wuhu Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023jc24"],"award-info":[{"award-number":["2023jc24"]}],"id":[{"id":"10.13039\/501100014984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373294"],"award-info":[{"award-number":["82373294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10735-026-10802-6","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:43:05Z","timestamp":1776847385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PDK4 acts via hippo signaling to inhibit ferroptosis and reduce gemcitabine sensitivity in pancreatic cancer"],"prefix":"10.1007","volume":"57","author":[{"given":"Lei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"21","key":"10802_CR3","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.3390\/ijms242115787","volume":"24","author":"L Alberghina","year":"2023","unstructured":"Alberghina L, The Warburg Effect Explained (2023) Integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation. Int J Mol Sci 24(21):15787. https:\/\/doi.org\/10.3390\/ijms242115787","journal-title":"Int J Mol Sci"},{"key":"10802_CR5","doi-asserted-by":"publisher","first-page":"583217","DOI":"10.3389\/fonc.2020.583217","volume":"10","author":"E Atas","year":"2020","unstructured":"Atas E, Oberhuber M, Kenner L (2020) The implications of PDK1-4 on tumor energy metabolism, aggressiveness and therapy resistance. Front Oncol 10:583217. https:\/\/doi.org\/10.3389\/fonc.2020.583217","journal-title":"Front Oncol"},{"issue":"10","key":"10802_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.trecan.2021.04.005","volume":"7","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D (2021) Targeting ferroptosis in pancreatic cancer: a double-edged sword. Trends Cancer 7(10):891\u2013901. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.005","journal-title":"Trends Cancer"},{"key":"10802_CR13","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, Tang D (2020) Iron Metabolism in Ferroptosis. Front Cell Dev Biol 8:590226. https:\/\/doi.org\/10.3389\/fcell.2020.590226","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"10802_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41575-021-00486-6","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Zeh HJ, Kang R, Kroemer G, Tang D (2021) Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol 18(11):804\u2013823. https:\/\/doi.org\/10.1038\/s41575-021-00486-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10802_CR14","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, Remi\u00e3o F, Silva R (2023) Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther 244:108373. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10802_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/cbm-210212","volume":"34","author":"Z Cui","year":"2022","unstructured":"Cui Z, Wang Q, Deng MH, Han QL (2022) LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis. Cancer Biomark 34(1):41\u201353. https:\/\/doi.org\/10.3233\/cbm-210212","journal-title":"Cancer Biomark"},{"issue":"29","key":"10802_CR32","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.2174\/0929867329666220922102949","volume":"30","author":"X Dai","year":"2023","unstructured":"Dai X, Chen K, Xie Y (2023) WTAP mediated the N6-methyladenosine modification of PDK4 to regulate the malignant behaviors of colorectal cancer cells in vitro and in vivo. Curr Med Chem 30(29):3368\u20133381. https:\/\/doi.org\/10.2174\/0929867329666220922102949","journal-title":"Curr Med Chem"},{"issue":"6","key":"10802_CR20","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1097\/hep.0000000000000326","volume":"77","author":"K Du","year":"2023","unstructured":"Du K, Maeso-D\u00edaz R, Oh SH, Wang E, Chen T, Pan C, Xiang K, Dutta RK, Wang XF, Chi JT, Diehl AM (2023) Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis. Hepatology 77(6):1998\u20132015. https:\/\/doi.org\/10.1097\/hep.0000000000000326","journal-title":"Hepatology"},{"issue":"7","key":"10802_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad083","volume":"164","author":"AR Dwyer","year":"2023","unstructured":"Dwyer AR, Perez Kerkvliet C, Truong TH, Hagen KM, Krutilina RI, Parke DN, Oakley RH, Liddle C, Cidlowski JA, Seagroves TN, Lange CA (2023) Glucocorticoid receptors drive breast cancer cell migration and metabolic reprogramming via PDK4, Endocrinology 164(7):bqad083. https:\/\/doi.org\/10.1210\/endocr\/bqad083","journal-title":"Endocrinology"},{"issue":"4","key":"10802_CR7","doi-asserted-by":"publisher","first-page":"e13800","DOI":"10.1111\/acel.13800","volume":"22","author":"MK Fatmi","year":"2023","unstructured":"Fatmi MK, Ren D, Fedorova J, Zoungrana LI, Wang H, Davitt K, Li Z, Iglesias M, Lesnefsky EJ, Krause-Hauch M, Li J (2023) Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging. Aging Cell 22(4):e13800. https:\/\/doi.org\/10.1111\/acel.13800","journal-title":"Aging Cell"},{"issue":"11","key":"10802_CR24","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.cmet.2022.09.005","volume":"34","author":"E Fern\u00e1ndez-Vizarra","year":"2022","unstructured":"Fern\u00e1ndez-Vizarra E, L\u00f3pez-Calcerrada S, Sierra-Magro A, P\u00e9rez-P\u00e9rez R, Formosa LE, Hock DH, Illescas M, Pe\u00f1as A, Brischigliaro M, Ding S, Fearnley IM, Tzoulis C, Pitceathly RDS, Arenas J, Mart\u00edn MA, Stroud DA, Zeviani M, Ryan MT, Ugalde C (2022) Two independent respiratory chains adapt OXPHOS performance to glycolytic switch. Cell Metab 34(11):1792\u20131808e6. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.005","journal-title":"Cell Metab"},{"issue":"7","key":"10802_CR6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/cvr\/cvad038","volume":"119","author":"MJ Forteza","year":"2023","unstructured":"Forteza MJ, Berg M, Edsfeldt A, Sun J, Baumgartner R, Kareinen I, Casagrande FB, Hedin U, Zhang S, Vuckovic I, Dzeja PP, Polyzos KA, Gister\u00e5 A, Trauelsen M, Schwartz TW, Dib L, Herrmann J, Monaco C, Matic L, Gon\u00e7alves I, Ketelhuth DFJ (2023) Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk. Cardiovasc Res 119(7):1524\u20131536. https:\/\/doi.org\/10.1093\/cvr\/cvad038","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10802_CR16","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ymthe.2023.07.026","volume":"31","author":"L Gao","year":"2023","unstructured":"Gao L, Zhang J, Yang T, Jiang L, Liu X, Wang S, Wang X, Huang Y, Wang H, Zhang M, Gong T, Ma L, Li C, He C, Meng XM, Wu Y (2023) STING\/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease. Mol Ther 31(10):3084\u20133103. https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.026","journal-title":"Mol Ther"},{"issue":"1","key":"10802_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/1878-0261.13025","volume":"16","author":"EP Jane","year":"2022","unstructured":"Jane EP, Premkumar DR, Rajasundaram D, Thambireddy S, Reslink MC, Agnihotri S, Pollack IF (2022) Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Mol Oncol 16(1):219\u2013249. https:\/\/doi.org\/10.1002\/1878-0261.13025","journal-title":"Mol Oncol"},{"key":"10802_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.14336\/ad.2023.1227","volume":"16","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, He J, Zhang B, Wang L, Long C, Zhao B, Yang Y, Du L, Luo W, Hu J, Hong X (2024) A potential anti-warburg effect in circulating tumor cell-mediated metastatic progression? Aging Dis 16:269\u2013282. https:\/\/doi.org\/10.14336\/ad.2023.1227","journal-title":"Aging Dis"},{"issue":"1","key":"10802_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/ijo.2021.5220","volume":"59","author":"CJ Kim","year":"2021","unstructured":"Kim CJ, Terado T, Tambe Y, Mukaisho KI, Kageyama S, Kawauchi A, Inoue H (2021) Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR\/\u03b2\u2013catenin\/N\u2013cadherin axis. Int J Oncol 59(1):40. https:\/\/doi.org\/10.3892\/ijo.2021.5220","journal-title":"Int J Oncol"},{"issue":"11","key":"10802_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5483\/BMBRep.2022.55.11.089","volume":"55","author":"DH Kim","year":"2022","unstructured":"Kim DH, Kim MJ, Kim NY, Lee S, Byun JK, Yun JW, Lee J, Jin J, Kim J, Chin J, Cho SJ, Lee IK, Choi YK, Park KG (2022) DN200434, an orally available inverse agonist of estrogen-related receptor \u03b3, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma. BMB Rep 55(11):547\u2013552. https:\/\/doi.org\/10.5483\/BMBRep.2022.55.11.089","journal-title":"BMB Rep"},{"issue":"3","key":"10802_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/jmf.2022.K.0061","volume":"26","author":"HY Kim","year":"2023","unstructured":"Kim HY, Moon JY, Cho SK (2023) Heptadecanoic acid, an odd-chain fatty acid, induces apoptosis and enhances gemcitabine chemosensitivity in pancreatic cancer cells. J Med Food 26(3):201\u2013210. https:\/\/doi.org\/10.1089\/jmf.2022.K.0061","journal-title":"J Med Food"},{"issue":"20","key":"10802_CR37","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/cells12202509","volume":"12","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Kim HS, Kang HW, Lee DE, Hong WC, Kim JH, Kim M, Cheong JH, Kim HJ, Park JS (2023) SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer. Cells 12(20):2509. https:\/\/doi.org\/10.3390\/cells12202509","journal-title":"Cells"},{"issue":"5","key":"10802_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.14348\/molcells.2023.2128","volume":"46","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Lee H, Chanda D, Thoudam T, Kang HJ, Harris RA, Lee IK (2023) The role of pyruvate metabolism in mitochondrial quality control and inflammation. Mol Cells 46(5):259\u2013267. https:\/\/doi.org\/10.14348\/molcells.2023.2128","journal-title":"Mol Cells"},{"issue":"3","key":"10802_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.20517\/cdr.2023.49","volume":"6","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi H, Yoshimoto C, Matsubara S, Shigetomi H, Imanaka S (2023) A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer. Cancer Drug Resist 6(3):547\u2013566. https:\/\/doi.org\/10.20517\/cdr.2023.49","journal-title":"Cancer Drug Resist"},{"issue":"13","key":"10802_CR43","doi-asserted-by":"publisher","first-page":"e157491","DOI":"10.1172\/jci.insight.157491","volume":"8","author":"WH Lin","year":"2023","unstructured":"Lin WH, Feathers RW, Cooper LM, Lewis-Tuffin LJ, Chen J, Sarkaria JN, Anastasiadis PZ (2023) A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma. JCI Insight 8(13):e157491. https:\/\/doi.org\/10.1172\/jci.insight.157491","journal-title":"JCI Insight"},{"key":"10802_CR23","doi-asserted-by":"publisher","first-page":"114847","DOI":"10.1016\/j.ejmech.2022.114847","volume":"244","author":"M Luo","year":"2022","unstructured":"Luo M, Xu Y, Chen H, Wu Y, Pang A, Hu J, Dong X, Che J, Yang H (2022) Advances of targeting the YAP\/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. Eur J Med Chem 244:114847. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114847","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10802_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH (2018) Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol 15(6):333\u2013348. https:\/\/doi.org\/10.1038\/s41575-018-0005-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10802_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12967-023-03928-8","volume":"21","author":"C Peng","year":"2023","unstructured":"Peng C, Zhang Y, Lang X, Zhang Y (2023) Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis. J Transl Med 21(1):66. https:\/\/doi.org\/10.1186\/s12967-023-03928-8","journal-title":"J Transl Med"},{"issue":"1","key":"10802_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s43018-022-00473-z","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M (2023) YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. Nat Cancer 4(1):9\u201326. https:\/\/doi.org\/10.1038\/s43018-022-00473-z","journal-title":"Nat Cancer"},{"issue":"6","key":"10802_CR26","doi-asserted-by":"publisher","first-page":"7778","DOI":"10.1096\/fj.201802799R","volume":"33","author":"F Pin","year":"2019","unstructured":"Pin F, Novinger LJ, Huot JR, Harris RA, Couch ME, O\u2019Connell TM, Bonetto A (2019) PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia. Faseb J 33(6):7778\u20137790. https:\/\/doi.org\/10.1096\/fj.201802799R","journal-title":"Faseb J"},{"key":"10802_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/tgh-23-27","volume":"8","author":"E Sarfaty","year":"2023","unstructured":"Sarfaty E, Khajoueinejad N, Zewde MG, Yu AT, Cohen NA (2023) Surgical management of pancreatic ductal adenocarcinoma: a narrative review. Transl Gastroenterol Hepatol 8:39. https:\/\/doi.org\/10.21037\/tgh-23-27","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10802_CR45","doi-asserted-by":"publisher","first-page":"103597","DOI":"10.1016\/j.redox.2025.103597","volume":"82","author":"G She","year":"2025","unstructured":"She G, Hai XX, Jia LY, Zhang YJ, Ren YJ, Pang ZD, Wu LH, Han MZ, Zhang Y, Li JJ, Bai RY, Lai BC, Yang YY, Sadoshima J, Du XJ, Deng XL, Zhang Y (2025) Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1. Redox Biol 82:103597. https:\/\/doi.org\/10.1016\/j.redox.2025.103597","journal-title":"Redox Biol"},{"issue":"4","key":"10802_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00432-024-05748-9","volume":"150","author":"W Shi","year":"2024","unstructured":"Shi W, Wang J, Chen J, Jin X, Wang Y, Yang L (2024) Abrogating PDK4 activates autophagy-dependent ferroptosis in breast cancer via ASK1\/JNK pathway. J Cancer Res Clin Oncol 150(4):218. https:\/\/doi.org\/10.1007\/s00432-024-05748-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10802_CR31","doi-asserted-by":"publisher","first-page":"2246198","DOI":"10.1080\/15384047.2023.2246198","volume":"24","author":"T Si","year":"2023","unstructured":"Si T, Huang L, Liang T, Huang P, Zhang H, Zhang M, Zhou X (2023) Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK4. Cancer Biol Ther 24(1):2246198. https:\/\/doi.org\/10.1080\/15384047.2023.2246198","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"10802_CR17","doi-asserted-by":"publisher","first-page":"108767","DOI":"10.1016\/j.celrep.2021.108767","volume":"34","author":"X Song","year":"2021","unstructured":"Song X, Liu J, Kuang F, Chen X, Zeh HJ 3rd, Kang R, Kroemer G, Xie Y, Tang D (2021) PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis. Cell Rep 34(8):108767. https:\/\/doi.org\/10.1016\/j.celrep.2021.108767","journal-title":"Cell Rep"},{"issue":"11","key":"10802_CR18","doi-asserted-by":"publisher","first-page":"e1010702","DOI":"10.1371\/journal.pcbi.1010702","volume":"18","author":"H Srivastava","year":"2022","unstructured":"Srivastava H, Lippincott MJ, Currie J, Canfield R, Lam MPY, Lau E (2022) Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners. PLoS Comput Biol 18(11):e1010702. https:\/\/doi.org\/10.1371\/journal.pcbi.1010702","journal-title":"PLoS Comput Biol"},{"key":"10802_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mito.2023.02.007","volume":"70","author":"PW Stacpoole","year":"2023","unstructured":"Stacpoole PW, McCall CE (2023) The pyruvate dehydrogenase complex: Life\u2019s essential, vulnerable and druggable energy homeostat. Mitochondrion 70:59\u2013102. https:\/\/doi.org\/10.1016\/j.mito.2023.02.007","journal-title":"Mitochondrion"},{"issue":"10","key":"10802_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1566524023666221021124202","volume":"23","author":"W Tan","year":"2023","unstructured":"Tan W, Bao H, Liu Z, Liu Y, Hong L, Shao L (2023) Protein PDK4 interacts with HMGCS2 to facilitate high glucoseinduced myocardial injuries. Curr Mol Med 23(10):1104\u20131115. https:\/\/doi.org\/10.2174\/1566524023666221021124202","journal-title":"Curr Mol Med"},{"issue":"5","key":"10802_CR22","doi-asserted-by":"publisher","first-page":"e1900162","DOI":"10.1002\/bies.201900162","volume":"42","author":"BJ Thompson","year":"2020","unstructured":"Thompson BJ (2020) Drivers of tumor growth, metastasis, and resistance to therapy. BioEssays 42(5):e1900162. https:\/\/doi.org\/10.1002\/bies.201900162","journal-title":"BioEssays"},{"key":"10802_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/cmar.S185015","volume":"11","author":"J Wang","year":"2019","unstructured":"Wang J, Qian Y, Gao M (2019) Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer. Cancer Manag Res 11:251\u2013262. https:\/\/doi.org\/10.2147\/cmar.S185015","journal-title":"Cancer Manag Res"},{"issue":"7769","key":"10802_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, Chen ZN, Jiang X (2019) Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572(7769):402\u2013406. https:\/\/doi.org\/10.1038\/s41586-019-1426-6","journal-title":"Nature"},{"issue":"7","key":"10802_CR15","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, Kroemer G, Chen X, Tang D, Liu J (2023) Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19(7):1982\u20131996. https:\/\/doi.org\/10.1080\/15548627.2023.2165323","journal-title":"Autophagy"},{"issue":"20","key":"10802_CR39","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3390\/ijms222010944","volume":"22","author":"J Yang","year":"2021","unstructured":"Yang J, Xu J, Zhang B, Tan Z, Meng Q, Hua J, Liu J, Wang W, Shi S, Yu X, Liang C (2021) Ferroptosis: at the crossroad of gemcitabine resistance and tumorigenesis in pancreatic cancer. Int J Mol Sci 22(20):10944. https:\/\/doi.org\/10.3390\/ijms222010944","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10802_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/iovs.61.13.29","volume":"61","author":"F Yemanyi","year":"2020","unstructured":"Yemanyi F, Raghunathan V (2020) Lysophosphatidic acid and IL-6 trans-signaling interact via YAP\/TAZ and STAT3 signaling pathways in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 61(13):29. https:\/\/doi.org\/10.1167\/iovs.61.13.29","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10802_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/cmar.S280307","volume":"13","author":"T Zhang","year":"2021","unstructured":"Zhang T, Li M, Lu H, Peng T (2021) Up-regulation of circEIF6 contributes to pancreatic cancer development through targeting miR-557\/SLC7A11\/PI3K\/AKT signaling. Cancer Manag Res 13:247\u2013258. https:\/\/doi.org\/10.2147\/cmar.S280307","journal-title":"Cancer Manag Res"},{"issue":"7","key":"10802_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, Wang X, Zhang B, Qian W, Wu Z, Ma Q, Wang Z (2022) Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis 13(7):630. https:\/\/doi.org\/10.1038\/s41419-022-05082-3","journal-title":"Cell Death Dis"},{"issue":"1","key":"10802_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12903-022-02503-9","volume":"22","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Wang X, Zhang Y, Wang L, Chen Z (2022) Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis. BMC Oral Health 22(1):478. https:\/\/doi.org\/10.1186\/s12903-022-02503-9","journal-title":"BMC Oral Health"},{"issue":"1","key":"10802_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-023-02671-8","volume":"42","author":"T Zhou","year":"2023","unstructured":"Zhou T, Xie Y, Hou X, Bai W, Li X, Liu Z, Man Q, Sun J, Fu D, Yan J, Zhang Z, Wang Y, Wang H, Jiang W, Gao S, Zhao T, Chang A, Wang X, Sun H, Zhang X, Yang S, Huang C, Hao J, Liu J (2023) Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo\/YAP1\/c-Jun axis. J Exp Clin Cancer Res 42(1):111. https:\/\/doi.org\/10.1186\/s13046-023-02671-8","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10802-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:48:55Z","timestamp":1782100135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10802-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10802"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10802-6","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was granted by the Medical Ethics Committee of Wannan Medical College (Approval No: WDRM 2023-65) in accordance with the Declaration of Helsinki. Informed written consent was obtained from all participants. All animal procedures were also conducted in accordance with the ethical guidelines of Institutional Animal Care and Use Committee (IACUC) and approved by the Ethics Committee of Wannan Medical College (No. WNMC-AWE-2023085).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"146"}}